Join us for an in-depth exploration of the critical role of drug delivery systems, focusing on the nasal, pulmonary, ocular, and dermal routes. These advances in delivery methods are reshaping modern therapeutics by providing significant advantages over traditional oral or intravenous methods, including enhanced patient compliance, targeted treatment, and improved bioavailability.
The seminar highlights how these systems are revolutionising the landscape of personalised medicine to reduce invasiveness and improve treatment precision. By expanding therapeutic options and boosting patient outcomes, these innovative routes are at the forefront of drug formulation advancements.
Targeting the lungs directly allows for lower doses, reducing side effects and maximizing therapeutic impact, particularly for respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery holds potential for treating systemic diseases due to the large surface area and high permeability of the alveolar region, allowing for rapid absorption in the bloodstream
Nasal route can be used for both local and systemic drug delivery. The nasal route is being explored for central nervous system conditions, like epilepsy, Alzheimer’s, etc. Nasal delivery also supports self-administration and rapid absorption through the nasal mucosa, making it crucial for conditions requiring immediate therapeutic effects, such as migraines and certain emergency medications
The eye is a delicate organ that requires targeted approaches to address conditions such as glaucoma, dry eye and retinal diseases. Preservatives in eye drops affect the retinal surface especially on long term usage. Preservative free delivery systems can help eliminate preservatives from formulations thereby reducing these side effect
The skin provides an accessible and non-invasive route for systemic or localized drug delivery. This route is highly suitable for drugs that are poorly absorbed orally or prone to degradation in the digestive tract
Date: Tuesday 3 December 2024
Time (AEDT):
8:45 am: Guest arrival and registration
9:00 am: Networking tea and coffee
9:30 am: Welcome and opening remarks
9:35 am: Presentations and Q&A
10:55 am: Closing remarks
11:00 am: Networking lunch
12:00 pm: Close
Format: In-person only
Venue: Burke & Wills Suite, Batman’s Hill on Collins, 623 Collins Street, Melbourne 3000, VIC
Speakers:
Shraddha Dangat, Senior Manager, Sales and Service Champion SEA, Aptar Pharma
Pankaj Sonawane, Director, Sales & Customer Service, India and SEA, Aptar Pharma
Dr Shadab Haque, Senior Research Scientist – Biologics, Medicines Manufacturing Innovation Centre
Dr Grant Mclachlan PhD, Director, CMC Program Management, ENA Respiratory
Host: Karen Parr, CEO, BioMelbourne Network
Free to attend for Members and Non Members, registration is essential.
Unsure if your organisation is a member? Check our member directory.
BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.
We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.